Thrombosis
Conference Coverage
EHR-based thromboembolism risk tool boosted prophylaxis
A thromboembolism risk calculator in a hospital’s EHR led to a significant rise in appropriate thromboprophylaxis and a drop in thromboembolic...
Conference Coverage
Combo thrombolytic approach fails to reduce ICH in stroke
Although there were promising signs of a potential reduced bleeding risk in intracranial hemorrhage, the DUMAS study showed no benefit on the...
From the Journals
Best anticoagulant for minimizing bleeding risk identified
“Apixaban stood out as having lower risk of gastrointestinal bleeding.”
Conference Coverage
Collateral flow flags stroke patients for late thrombectomy
The MR CLEAN-LATE trial shows patients selected for thrombectomy on the presence of collateral flow had a greater chance of a better functional...
Feature
Apixaban outmatches rivaroxaban in patients with AFib and valvular heart disease
Compared with rivaroxaban, patients who received apixaban had a 43% reduced risk of stroke or embolism.
From the Journals
New deep dive into Paxlovid interactions with CVD meds
The review tackles potential drug-drug interactions with the antiviral drug and today’s most commonly prescribed cardiovascular drugs.
Conference Coverage
New ESC guidelines for cutting CV risk in noncardiac surgery
The guidelines, which aim to reduce cardiovascular complications from noncardiac surgery, introduce new concepts and recommendations, compared...
News
Blood type linked to higher risk for early onset stroke
“The risk of stroke due to blood type is smaller than other risk factors that we know about, like smoking and hypertension. I would be much more...
Conference Coverage
Rivaroxaban outmatched by VKAs for AFib in rheumatic heart disease
A striking and unexpected reduction in death with the use of predominantly warfarin was just one of the many surprises delivered by the INVICTUS...
Conference Coverage
AXIOMATIC-SSP: Cautious optimism on factor XI inhibitor in stroke
The new factor XI inhibitor antithrombotic, milvexian, showed promising results in a dose-finding phase 2 trial in patients with acute ischemic...
From the Journals
Low-dose edoxaban curbs stroke risk in elderly with AF, despite frailty
A subanalysis of ELDERCARE-AF suggests a very low 15-mg dose of edoxaban safely reduces stroke and systemic embolism in elderly patients with AF...